OR Air Setbacks May Not Affect Outcomes - Top-Institutions - MDSpire

OR Air Setbacks May Not Affect Outcomes

Findings suggest lower ventilation during idle periods may reduce energy use without worsening outcomes.

  • By

  • Andrea Surnit

  • April 27, 2026

  • 2 min

Share

Top Institutions in Surgery

Brief introduction explaining scope and methodology.

  • #1

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Surgical Quality Improvement
    • Hospital Epidemiology
    • Infection Control

  • #2

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Surgical Outcomes Research
    • Hospital Epidemiology
    • Infection Prevention

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Surgical Quality Improvement
    • Healthcare Operations
    • Infection Control

  • #4

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Surgical Outcomes
    • Hospital Epidemiology
    • Infection Prevention

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Surgical Quality
    • Hospital Operations
    • Infection Control

Original Source(s)

OR Air Setbacks May Not Affect Outcomes

  • by Andrea Surnit

  • April 27, 2026

Related Content

Microcirculation dysfunction and cardioprotection in cardiac surgery with cardiopulmonary bypass: mechanisms, monitoring, and therapeutic strategies

Psychologists, Physicians Scarcer in Rural Areas?

National survey data found lower per-capita representation across 23 occupations in nonmetropolitan communities, with the largest workforce differences observed among psychologists, physicians, and surgeons.

Chemoimmunotherapy Linked to HNSCC Response

Higher pathologic response rates with chemoimmunotherapy versus immunotherapy alone call for phase 3 trials, but survival implications remain unknown.